Evidence map›Paper›PMID 39585071›Full record

ReviewNeurology international2024

Alfonso Mata-Bermudez, Araceli Diaz-Ruiz, Luis Ricardo Silva-García, Eduardo Manuel Gines-Francisco, Roxana Noriega-Navarro, Camilo Rios, Héctor Alonso Romero-Sánchez, Diego Arroyo, Abraham Landa, Luz Navarro

Abstract readReview
In one paragraph

Review in Neurology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. "Journal of Parkinson's disease · 2026
    Review
  3. Dual Neuroprotective and Nephroprotective Effects ofInternational journal of molecular sciences · 2026
    Article
  4. Neuroprotective potential ofVeterinary world · 2026
    Review
  5. The Effect ofNeuroSci · 2025
    Article
  6. Review
  7. Evaluating the neuroprotective potential ofIn silico pharmacology · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alfonso Mata-BermudezDepartamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.ORCID 0000-0002-2234-7019
Araceli Diaz-RuizDepartamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suarez, Ciudad de México 14269, Mexico.ORCID 0000-0002-1481-0966
Luis Ricardo Silva-GarcíaDepartamento de Atención a la Salud, Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México 04960, Mexico.ORCID 0009-0002-6735-9774
Eduardo Manuel Gines-FranciscoDepartamento de Atención a la Salud, Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México 04960, Mexico.
Roxana Noriega-NavarroDepartamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.ORCID 0000-0003-4724-569X
Camilo RiosLaboratorio de Neurofarmacología Molecular, Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México 04960, Mexico.
Héctor Alonso Romero-SánchezDepartamento de Atención a la Salud, Universidad Autónoma Metropolitana Unidad Xochimilco, Ciudad de México 04960, Mexico.
Diego ArroyoDepartamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.ORCID 0000-0001-5624-6171
Abraham LandaDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.
Luz NavarroDepartamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.ORCID 0000-0002-5519-0871

Funding

Universidad Nacional Autónoma de México DGAPA-PAPIITIN228223
6 · The paper itself

Abstract

Depression is a mental disorder that depicts a wide variety of symptoms, including mood and cognitive alterations, as well as recurrent thoughts of death or suicide. It could become the second leading cause of premature death or disability worldwide. Treatments with conventional antidepressants have several limitations in terms of effectiveness, side effects, and high costs. Therefore, medicinal plants such as

Indexed as

catecholaminescortisoldepressioninflammatory responseMucuna pruriensnitric oxideoxidative stress

Identifiers

PMID39585071
PMCPMC11587415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.